The Israeli startup’s technology transforms smartphones into clinical-grade motion analysis tools, helping healthcare providers assess, treat, and monitor patients from anywhere.
Israel startup OneStep has raised $36 million in a Series B funding round led by venture capital firms Team8 and Vintage Investment Partners, with participation from existing investors Aleph, 10D, and LionBird. This brings the total investment in the company since its inception to $48 million.
Full list of Israeli high-tech funding rounds in 2024
OneStep’s technology transforms smartphones into clinical-grade motion analysis tools, helping healthcare providers assess, treat, and monitor patients from anywhere. Gait (i.e. human motion) is a leading indicator of health, and by making gait analysis simple, OneStep provides clinicians with actionable data to improve mobility, reduce falls, and enhance patient engagement.
The FDA-approved product is widely used by hospitals, physical therapy clinics, nursing homes, and medical device manufacturers. Recently, OneStep expanded into cognitive monitoring to address conditions like Alzheimer’s and Parkinson’s.
Currently, gait analysis is performed only in specialized labs that cost hundreds of thousands of dollars, require appointments months in advance, and involve multiple sensors, making the assessment a one-time event. OneStep, however, allows for gait measurement in just 5 seconds—users only need to place their phone in their pocket and take a few steps. The results are immediate, with continuous and passive monitoring. OneStep generates 40 different metrics, including step length, time spent on each leg, range of motion in various joints, and more.
OneStep was founded in late 2019 by CEO Tomer Shussman, Chief Scientific Officer Yuval Naveh, CTO Shahar Davidson, and Executive Chairman Amir Milo. All four founders are graduates of the IDF’s Talpiot program and sought to leverage smartphone capabilities for continuous medical monitoring. The company currently employs about 50 people, with most based in the development center in Tel Aviv and the rest in the U.S.
“Our vision is for gait measurement to become a daily activity, just like weighing yourself in the morning. We started in the rehabilitation space, where we help patients recover 45% faster and reduce falls in the elderly by 20%, while also generating profit and saving time for treatment centers. Ultimately, we estimate that 1 in 4 people will need to continuously monitor their walking,” said Tomer Shussman, co-founder and CEO of OneStep.
